arrow
C

Catherine Bourassa

université de montréal
H指数:20
被引数:1,980

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characterization of oseltamivir-resistant A(H5N1) clade 2.3.4.4b, genotype D1.1 variants identified in poultry farms of British Columbia, Canada

加拿大不列颠哥伦比亚省禽类农场中分离的奥司他韦耐药A(H5N1) 2.3.4.4b亚群D1.1基因型变异体的表征

2026-07-080
OAAI
The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC

HIV-1 Env的对称性开启由一种强效的CD4模拟物实现,这使抗共受体结合位点抗体能够介导ADCC。

2025-12-010
OAAI
Safety, pharmacokinetics, and biological activity of CD4-mimetic BNM-III-170 in SHIV-infected rhesus macaques
2025-04-010
OAAI
CD4 downregulation precedes Env expression and protects HIV-1-infected cells from ADCC mediated by non-neutralizing antibodies
MBIO
IF4.7
2024-11-130
OAAI
The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity
2024-10-220
PRE
Three families of CD4-induced antibodies are associated with the capacity of plasma from people living with HIV to mediate ADCC in the presence of CD4-mimetics

CD4-induced抗体的三个家族与HIV感染者血浆在存在CD4-mimetics的情况下介导ADCC的能力有关。

2024-10-222
OA
NTB-A and 2B4 Natural Killer Cell Receptors Modulate the Capacity of a Cocktail of Non-Neutralizing Antibodies and a Small CD4-Mimetic to Eliminate HIV-1-Infected Cells by Antibody-Dependent Cellular Cytotoxicity
2024-07-201
OAAI
Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity

持续的IFN信号传导与SARS-CoV-2-specific免疫的延迟发展有关

2024-05-163
OAAI
Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis
2024-02-237
OAAI
Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy-Treated Individuals With Undetectable Viremia
2023-11-306
OAAI
Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120
2023-05-0112
OAAI
Indoline CD4-mimetic compounds mediate potent and broad HIV-1 inhibition and sensitization to antibody-dependent cellular cytotoxicity
2023-03-248
OAAI